At the news
? MIXEDIMPACT 6/10 CLUSTER filed Aug 7, 2026 at 16:16 ET
Boston Scientific CEO Michael Mahoney and Director David Habiger made open-market purchases totaling $9.1M, with the CEO alone buying $9.0M worth of shares at $48.33. This insider buying cluster follows a Q2 earnings beat that was overshadowed by a significant guidance cut and a $700M-$800M restructuring plan filed 14 days prior. The CEO's large personal investment signals confidence in the company's turnaround, but the material guidance reduction and restructuring charges create a conflicting picture for traders.
- CEO Michael Mahoney purchased 186,200 shares for $9.0M at $48.33 on 2026-08-03
- Director David Habiger purchased 2,100 shares for $100K at $47.59 on 2026-08-05
- Total insider buying cluster value: $9.1M, representing approximately 0.012% of $74.2B market cap
- CFO Jonathan Monson made a discretionary sale of 9,908 shares for ~$500K on 2026-08-10
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access